URGN
UroGen Pharma Ltd.
$19.45
+$0.21(+1.09%)
75
Overall
--
Value
75
Tech
--
Quality
Market Cap
$902.15M
Volume
1.29M
52W Range
$3.42 - $21.02
Target Price
$33.67
EPS Estimates Overview
| Current Quarter | $-0.66 | Next Quarter | $-0.62 |
| Current Year | $-3.06 | Next Year | $-1.45 |
| QoQ Growth | +6.1% | YoY Growth | +52.6% |
| 3Y EPS CAGR | +12.1% | Target Price | $33.67 |
| Consensus | Buy | Upside | +73.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $19.45 | +1.1% | 1.29M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |